| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | 0.22 | 3e-06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-05 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0003 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0003 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0004 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0005 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | 0.21 | 0.0005 |